Ambroxol for the Prevention of Chronic Bronchitis Exacerbations: Long-Term Multicenter Trial

Dario Olivieri,Guido Zavattini,G. Tomasini,S. Daniotti,Giovanni Bonsignore,Giovanni Ferrara,N. Carnimeo,R. Chianese,Catena E,S. Marcatili,M. Del Donno,Carlo Grassi,Ernesto Pozzi,V Grassi,C. Tantucci,M. Lucchesi,G. Schimid,C.F. Marchioni,S. Penitenti,Mistretta A,Nunzio Crimi,Lucio Casali,R. Cabiddu,Claudio F. Donner,A. Patessio,V. Massei,C. M. Sanguinetti,Orlandi O,S. Bruna,C. Serra,A. Giacopelli

Ambroxol for the Prevention of Chronic Bronchitis Exacerbations: Long-Term Multicenter Trial

1987

In a 6-month, double-blind multicenter trial conducted over the winter, the effects of daily administration of ambroxol retard (75 mg) were compared with those of placebo in preventing exacerbations a

Keywords:

Anesthesia
Bronchitis
Placebo
Multicenter trial
Ambroxol
Physical therapy
Intensive care medicine
Medicine
chronic bronchitis
long term treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations